Part II3 IB:l Labeling Annotated

First Page		Document Content
Moroctocog alfa Haemophilia Coagulation Von Willebrand disease Factor VII Factor X Desmopressin Thrombin Factor IX Coagulation system Blood Biology		Part II3 IB:l Labeling Annotated Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 1,04 MB Share Document on Facebook

	Microsoft Word - Report Coagulation Factors June 2013 DocID: M8ar - View Document
	Summary Basis for Regulatory Action Date: [removed]From: Irwin M. Feuerstein, M.D., M.S., M.B.A., Chair of the BLA BLA/STN#: [removed]Applicant Name: Pfizer Incorporated / Wyeth Biopharma Division of Wyeth Pharmaceu DocID: I02q - View Document
	RECOMBINATE [Antihemophilic Factor (Recombinant)] Lyophilized Powder for Reconstitution for injection Reconstitute with 10 mL of Sterile Water for Injection using Baxject II DESCRIPTION DocID: HU3U - View Document
	RECOMBINATE [Antihemophilic Factor (Recombinant)] Lyophilized Powder for Reconstitution for injection Reconstitute with 5 mL of Sterile Water for Injection using Baxject II DESCRIPTION DocID: HTdJ - View Document
	RECOMBINATE Antihemophilic Factor (Recombinant) Lyophilized Powder for Reconstitution for injection Reconstitute with 5 mL of Sterile Water for Injection using double-ended needles DocID: HNXB - View Document